PS Ratio: 22.18

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 22.18 is 72% below its estimated 1-year average of 78.08, near the low end of its estimated 1-year range (22.18–138.87).

As of 2026-10-06T18:55:55.013Z. 70.94% below its estimated 12-month average of 76.33.

BIOA PS Ratio Metrics

P/S vs. estimated history

At 22.18, P/S is below its estimated 1-year median — higher than 0% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for BioAge Labs Inc. (BIOA)?

The P/S ratio for BIOA stock is 22.18.

Is BioAge Labs Inc.'s P/S ratio high or low?

The P/S ratio of 22.18 is 72% below its estimated 1-year average of 78.08, near the low end of its estimated 1-year range (22.18–138.87).

What is the estimated TTM average P/S ratio for BioAge Labs Inc. (BIOA)?

The estimated TTM average P/S ratio for BIOA stock is 76.33.

Showing the most recent 260 of 355 data points. The chart above shows the full history.

Related Metrics